Logo.png
Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business
May 23, 2024 15:00 ET | Guardion Health Sciences, Inc.
 Adjourns Special Meeting to May 31, 2024 in order to Solicit Additional Proxies in Support of its Plan of Liquidation and Dissolution HOUSTON, TEXAS, May 23, 2024 (GLOBE NEWSWIRE) -- Guardion...
Logo.png
Guardion Health Sciences Announces its Largest Stockholder Has Voted in Favor of Proposals to Sell the Viactiv Business and the Liquidation Plan at the Company’s Special Meeting of Stockholders to be held on May 23, 2024
May 21, 2024 08:00 ET | Guardion Health Sciences, Inc.
Company Estimates the Aggregate Potential Liquidating Distributions to Range from approximately $9.00 to $11.00 per Share if Stockholders Vote to Approve the Sale of the Company’s Viactiv Business and...
Logo.png
Guardion Health Sciences Announces
May 13, 2024 17:01 ET | Guardion Health Sciences, Inc.
-- Financial Results for the Three Months Ended March 31, 2024 -- Institutional Shareholder Services Issues Report Recommending that Institutional Stockholders Vote in Favor of All Proposals at...
Logo.png
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
March 29, 2024 06:15 ET | Guardion Health Sciences, Inc.
Viactiv® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022 ...
Logo.png
Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc.
January 30, 2024 18:13 ET | Guardion Health Sciences, Inc.
HOUSTON, TEXAS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) announced today that it has signed an equity purchase agreement to sell...
Logo.png
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023
November 13, 2023 16:10 ET | Guardion Health Sciences, Inc.
Viactiv® Generated Net Revenues of Approximately $3.3 Million for the Three Months Ended September 30, 2023, an increase of 27% over the Three Months Ended September 30, 2022 HOUSTON, TEXAS, Nov. ...
Logo.png
Guardion Health Sciences, Inc. Announces Proposed Public Offering
February 17, 2022 09:00 ET | Guardion Health Sciences, Inc.
HOUSTON, TEXAS, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported...
Logo.png
Guardion Provides Answers to Frequently Asked Questions Regarding the Reasons for Approving the Reverse Stock Split Proposal at Upcoming 2020 Annual Stockholders’ Meeting
October 27, 2020 08:30 ET | Guardion Health Sciences, Inc.
SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) is providing the following answers to frequently asked questions to its...
Logo.png
Guardion Provides Answers to Frequently Asked Questions Regarding the Reasons for Approving the Reverse Stock Split Proposal at Upcoming 2020 Annual Stockholders’ Meeting
October 27, 2020 08:30 ET | Guardion Health Sciences, Inc.
SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) is providing the following answers to frequently asked questions to its...
Logo.png
Guardion Announces Virtual Annual Meeting of Stockholders
September 11, 2020 17:20 ET | Guardion Health Sciences, Inc.
Annual stockholder meeting scheduled for Thursday, October 29, 2020 San Diego, California, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc.(“Guardion” or the...